Determination of Fibrinogen and Fibrinogenolytic Activity^[*]

Summary

A method for determining plasma fibrinogen and fibrinogenolytic activity, with epsilonaminocaproic acid (ε-ACA) as an inhibitor of fibrinolysis, in patients with high fibrinolytic activity, is described in detail.

The fibrinogen was determined by a modification of Morrison’s syneresis method in parallel in 1. citrated plasma that was incubated for 2 hours at 37° C, after which further digestion was prevented by addition of ε-ACA and is referred to as fibrinogen A, and 2. in citrated plasma prepared from blood collected in tubes containing ε-ACA to prevent activation of plasminogen and is referred to as fibrinogen B.

The difference between fibrinogen B and fibrinogen A gives the amount of lysed fibrinogen in 2 hours at 37° C. Fibrinogen B gives the fibrinogen concentration at the moment of sampling.

The method is recommended to be used for evaluation of the true plasma fibrinogen level and the degree of fibrinogenolytic activity. This is particularly important during thrombolytic therapy.

• References

• 1 Ablondi F. B, De Renzo E. C. Mechanism of clot lysis by streptokinase and effects of epsilon-aminocaproic acid.. Proc. Soc. exp. Biol. 1959; 102: 717
• 2 Ablondi F. B, Hagan J. J, Philips M, De Renzo E. C. Inhibition of plasmin. trypsin and the streptokinase activated fibrinolytic system by epsilonamino-caproic acid. Arch. Biochem. 1959; 82: 153
• 3 Alkjaersig N. Laboratory control of the thrombolytic state.. Proc. Conf. Thrombolytic Agents. Chicago 1960: 136
• 4 Alkjaersig N, Fletcher A. P, Sherry S. Epsilon-aminocaproic acid: an inhibitor of plasminogen activation.. J. Biol. Chem. 1959; 234: 832
• 5 Andersson L, Nilsson I. M. Effect of e-amino-n-caproic acid (e-ACA) on fibrinolysis and bleeding conditions in prostatic disease.. Acta Chir. Scand. 1961; 121: 291
• 6 Bang N. U. Studies by the electrone-microscope.. Thrombos. Diathes. haemorrh. 1961; 6 Suppl. 1 262
• 7 Bang N. U, Balstrup F, Iversen K. Enzymatisk trombolytisk terapi.. Ugeskr. Laeg. 1962; 124: 523
• 8 Bergström K, Blombäck B, Kleen G. Studies on the plasma-fibrinolytic activity in a case of liver cirrhosis.. Acta Med. Scand. 1960; 168: 291
• 9 Björkman S. E, Laurell C. B, Nilsson I. M. Serum proteins and fibrinolysis in polycythaemia vera.. Scand. J. clin. Lab. Invest. 1956; 8: 304
• 10 Blix S. Effect of fibrinogen, blood transfusion, and epsilon-amino-caproic acid in two patients with fibrinolytic activity.. Acta Med. Scand. 1961; 169: 71
• 11 Blix S. Studies on the fibrinolytic system in the euglobulin fraction of human plasma. Scand. J. clin. Lab. Invest. 1961; 13 suppl. 58
• 12 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen.. Arkiv för kemi 1956; 10: 415
• 13 Celander D. R, Naschke M. D, Guest M. M. The effect of E-amino-caproic acid on fibrinolysin and on activators of Profibrinolysin.. Texas Rep. Biol. Med. 1961; 19: 50
• 14 Deutsch E, Fischer M. Die Wirkung intravenös applizierter Streptokinase auf Fibrinolyse und Blutgerinnung.. Thrombos. Diathes. haemorrh. 1960; 4: 482
• 15 Fletcher A. P. Pathophysiology of thrombolysis.. Proc. Conf. Thrombolytic agents. Chicago 1960: 148
• 16 Fletcher A. P, Alkjaersig N, Sherry S. The pathogenesis of the haemor-rhagic diathesis developing during “fibrinolytic” states: the significance of defective fibrin polymerization.. J. Clin. Invest. 1959; (Abstract). 38: 1005
• 17 Igawa T, Watanabe H, Amano M, Okamoto S. Viscosimetric study of the action of e-amino-caproic acid on human plasmin.. Keio Med. J. 1959; 8: 225
• 18 Jacobsson K. Studies on fibrinogen.. Scand. J. Clin. Lab. Invest. 1955; 7 suppl. 14
• 19 Kowalski E. Fibrinogen derived inhibitors of blood coagulation.. Thrombos. Diathes. haemorrh. 4: 211 Suppl. 1960;
• 20 McNicol G. P, Fletcher A. P, Alkjaersig N, Sherry S. The use of epsilonaminocaproic acid, a potent inhibitor of fibrinolytic activity, in the management of postoperative haematuria.. J. Urol. 1961; 86: 829
• 21 Morrison P. R. Preparation and properties of serum and plasma proteins. IV. Some factors influencing the quantitative determination of fibrinogen.. J. Amer. Chem. Soc. 1947; 69: 2723
• 22 Niewiarowski S, Kowalski E. Antithrombin formation during proteolysis of fibrinogen.. Trans. 6th Congress Europ. Soc. Haematology, Copenhagen Karger; Basel/New York: 1957: 560
• 23 Nilsson I. M, Blombäck M, Francken I. V. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time.. Acta med. Scand. 1957; 159: 35
• 24 Nilsson I. M, Sjoerdsma A, Waldenström J. Antifibrinolytic activity and metabolism of E-aminocaproic acid in man.. Lancet I: 1322 1960;
• 25 Nilsson I. M, Björkman S. E, Andersson L. Clinical experiences with e-aminocaproic acid (e-ACA) as an antifibrinolytic agent.. Acta Med. Scand. 1961; 170: 487
• 26 Nilsson I. M, Blombäck M, Ramgren O. Haemophilia in Sweden.. I. Coagulation studies. Acta Med. Scand. 1961; 170: 665
• 27 Nilsson I. M, Olow B. Fibrinolysis induced by streptokinase in man.. Acta Chir. Scand. 1962; 123: 247
• 28 Olow B, Nilsson I. M. Streptokinase induced fibrinolysis in man.. Trans. 8th Congress Europ. Soc. Haematology, Vienna Karger; Basel/New York: 1962: 444
• 29 Olow B, Nilsson I. M. Fibrinolysis induced by streptokinase in man.. II. Studies with large doses of streptokinase alone and streptokinase combined with epsilonaminocaproic acid. Acta Chir. Scand. (In press).
• 30 Sawyer W. D, Alkjaersig N, Fletcher A. P, Sherry S. A comparison of the fibrinolytic and fibrinogenolytic effects of plasminogen activators and proteolytic enzymes in plasma.. Thrombos. Diathes. haemorrh. 1961; 5: 149
• 31 Sherry S, Fletcher A. P, Alkjaersig N, Sawyer W. D. Epsilonaminocaproic acid: an inhibitor of plasminogen activation.. Trans. Ass. Amer. Phycus 1959; 72: 62
• 32 Takeshi A, Akira S. Reaction mechanism between e-aminocaproic acid and plasmin. tissue activator and trypsin. Keio Med. J. 1959; 8: 219
• 33 Troll W, Sherry S, Wachman J. Action of plasmin on synthetic substrates.. J. Biol. Chem. 208: 85 1954;